These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 25881065)

  • 1. The 4-aminopiperidine series has limited anti-tubercular and anti-staphylococcus aureus activity.
    Chandrasekera NS; Alling T; Bailey M; Korkegian A; Ahn J; Ovechkina Y; Odingo J; Parish T
    J Negat Results Biomed; 2015 Feb; 14():4. PubMed ID: 25881065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and structure-activity relationships evaluation of benzothiazinone derivatives as potential anti-tubercular agents.
    Gao C; Ye TH; Wang NY; Zeng XX; Zhang LD; Xiong Y; You XY; Xia Y; Xu Y; Peng CT; Zuo WQ; Wei Y; Yu LT
    Bioorg Med Chem Lett; 2013 Sep; 23(17):4919-22. PubMed ID: 23886691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis, biological activity, and SAR of antimycobacterial 2- and 8-substituted 6-(2-furyl)-9-(p-methoxybenzyl)purines.
    Braendvang M; Gundersen LL
    Bioorg Med Chem; 2007 Nov; 15(22):7144-65. PubMed ID: 17804243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 6-hydrogen-8-methylquinolones active against replicating and non-replicating Mycobacterium tuberculosis.
    Tabarrini O; Sabatini S; Massari S; Pieroni M; Franzblau SG; Cecchetti V
    Chem Biol Drug Des; 2012 Nov; 80(5):781-6. PubMed ID: 22889240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design, synthesis and investigation on the structure-activity relationships of N-substituted 2-aminothiazole derivatives as antitubercular agents.
    Pieroni M; Wan B; Cho S; Franzblau SG; Costantino G
    Eur J Med Chem; 2014 Jan; 72():26-34. PubMed ID: 24333612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel aryloxy azolyl chalcones with potent activity against Mycobacterium tuberculosis H37Rv.
    Marrapu VK; Chaturvedi V; Singh S; Singh S; Sinha S; Bhandari K
    Eur J Med Chem; 2011 Sep; 46(9):4302-10. PubMed ID: 21764184
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural requirements for the antitubercular quaternized triflupromazine pharmacophore.
    Kunciw DL; Liechty JJ; Mitchell MO; Wan B; Franzblau SG
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5679-80. PubMed ID: 22850215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Discovery of novel bis-oxazolidinone compounds as potential potent and selective antitubercular agents.
    Ang W; Ye W; Sang Z; Liu Y; Yang T; Deng Y; Luo Y; Wei Y
    Bioorg Med Chem Lett; 2014 Mar; 24(6):1496-501. PubMed ID: 24582981
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of antitubercular compounds based on a 4-quinolylhydrazone scaffold. Further structure-activity relationship studies.
    Gemma S; Savini L; Altarelli M; Tripaldi P; Chiasserini L; Coccone SS; Kumar V; Camodeca C; Campiani G; Novellino E; Clarizio S; Delogu G; Butini S
    Bioorg Med Chem; 2009 Aug; 17(16):6063-72. PubMed ID: 19620006
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination of anti-tuberculosis drugs with vitamin C or NAC against different Staphylococcus aureus and Mycobacterium tuberculosis strains.
    Khameneh B; Fazly Bazzaz BS; Amani A; Rostami J; Vahdati-Mashhadian N
    Microb Pathog; 2016 Apr; 93():83-7. PubMed ID: 26602814
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure-activity relationships for a series of quinoline-based compounds active against replicating and nonreplicating Mycobacterium tuberculosis.
    Lilienkampf A; Mao J; Wan B; Wang Y; Franzblau SG; Kozikowski AP
    J Med Chem; 2009 Apr; 52(7):2109-18. PubMed ID: 19271749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and anti-tubercular activity of novel alkyl substituted riminophenazine derivatives.
    Li YL; Zhang CL; Zhang DF; Lu Y; Wang B; Zheng MQ; Li C; Yin DL; Huang HH
    Yao Xue Xue Bao; 2012 Jun; 47(6):745-54. PubMed ID: 22919722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and evaluation of the 2,4-diaminoquinazoline series as anti-tubercular agents.
    Odingo J; O'Malley T; Kesicki EA; Alling T; Bailey MA; Early J; Ollinger J; Dalai S; Kumar N; Singh RV; Hipskind PA; Cramer JW; Ioerger T; Sacchettini J; Vickers R; Parish T
    Bioorg Med Chem; 2014 Dec; 22(24):6965-79. PubMed ID: 25456390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and antitubercular evaluation of benzothiazinones containing a piperidine moiety.
    Lv K; Tao Z; Liu Q; Yang L; Wang B; Wu S; Wang A; Huang M; Liu M; Lu Y
    Eur J Med Chem; 2018 May; 151():1-8. PubMed ID: 29601990
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thiazole-aminopiperidine hybrid analogues: design and synthesis of novel Mycobacterium tuberculosis GyrB inhibitors.
    Jeankumar VU; Renuka J; Santosh P; Soni V; Sridevi JP; Suryadevara P; Yogeeswari P; Sriram D
    Eur J Med Chem; 2013; 70():143-53. PubMed ID: 24148991
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-benzylidene-4-chromanones: a novel cluster of anti-tubercular agents.
    Das U; Lorand T; Dimmock SG; Perjesi P; Dimmock JR
    J Enzyme Inhib Med Chem; 2015 Apr; 30(2):259-63. PubMed ID: 24939095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of Phenoxyalkylbenzimidazoles with Antitubercular Activity.
    Chandrasekera NS; Alling T; Bailey MA; Files M; Early JV; Ollinger J; Ovechkina Y; Masquelin T; Desai PV; Cramer JW; Hipskind PA; Odingo JO; Parish T
    J Med Chem; 2015 Sep; 58(18):7273-85. PubMed ID: 26295286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discovery of novel antitubercular 3a,4-dihydro-3H-indeno[1,2-c]pyrazole-2-carboxamide/carbothioamide analogues.
    Ahsan MJ; Samy JG; Soni S; Jain N; Kumar L; Sharma LK; Yadav H; Saini L; Kalyansing RG; Devenda NS; Prasad R; Jain CB
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5259-61. PubMed ID: 21807509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and evaluation of diarylpiperazine derivatives as potent anti-tubercular agents.
    Penta A; Franzblau S; Wan B; Murugesan S
    Eur J Med Chem; 2015 Nov; 105():238-44. PubMed ID: 26498570
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective anti-tubercular purines: synthesis and chemotherapeutic properties of 6-aryl- and 6-heteroaryl-9-benzylpurines.
    Braendvang M; Gundersen LL
    Bioorg Med Chem; 2005 Dec; 13(23):6360-73. PubMed ID: 16081292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.